Fas-associated factor 1 and Parkinson's disease
- 1 September 2008
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 31 (3) , 309-315
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Environmental Health Sciences (ES012068)
- National Institute of Environmental Health Sciences (ES015777)
This publication has 31 references indexed in Scilit:
- Merging Mouse Transcriptome Analyses with Parkinson's Disease Linkage StudiesDNA Research, 2007
- Aggregated α-Synuclein Mediates Dopaminergic NeurotoxicityIn VivoJournal of Neuroscience, 2007
- Genomewide Association, Parkinson Disease, and PARK10The American Journal of Human Genetics, 2006
- Variable effects of chronic subcutaneous administration of rotenone on striatal histologyJournal of Comparative Neurology, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Dopamine miracle: From brain homogenate to dopamine replacementMovement Disorders, 2002
- Apoptosis Induced by Human Fas-Associated Factor 1, hFAF1, Requires Its Ubiquitin Homologous Domain, but Not the Fas-Binding DomainBiochemical and Biophysical Research Communications, 2001
- Identification and Characterization of Human Fas Associated Factor 1, hFAF1Biochemical and Biophysical Research Communications, 1999
- Apoptosis by Death FactorCell, 1997
- Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature, 1995